ACB — Aurora Cannabis Share Price
- CA$366.45m
- CA$398.19m
- CA$270.28m
- 32
- 85
- 34
- 49
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 19.88 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.64 | ||
Price to Tang. Book | 0.75 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.14 | ||
EV to EBITDA | 13.58 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 0.18% | ||
Return on Equity | 4.9% | ||
Operating Margin | 0.41% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 268.7 | 245.25 | 221.34 | 173.69 | 270.28 | 342.1 | 381.44 | 1.94% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Directors
- Ronald Funk NEC (64)
- Miguel Martin CEO (49)
- Glen Ibbott CFO
- Andre Jerome EVP
- Carey Squires EVP
- Jillian Swainson SEC
- Michael Singer DRC (57)
- Margaret Atkins IND (64)
- Norma Beauchamp IND (60)
- Theresa Firestone IND (66)
- Lance Friedmann IND (66)
- Chitwant Kohli IND
- Adam Szweras IND (49)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 21st, 2006
- Public Since
- September 26th, 2007
- No. of Employees
- 1,073
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange
- Shares in Issue
- 54,857,588

- Address
- 2207 90B Street Sw, LEDUC, T6X 1V8
- Web
- https://www.auroramj.com/
- Phone
- +1 6043625207
- Auditors
- KPMG LLP
Upcoming Events for ACB
Q1 2026 Aurora Cannabis Inc Earnings Release
Aurora Cannabis Inc Annual Shareholders Meeting
Similar to ACB
Aptose Biosciences
Toronto Stock Exchange
Auxly Cannabis
Toronto Stock Exchange
Bausch Health Companies
Toronto Stock Exchange
Canopy Growth
Toronto Stock Exchange
Charlotte's Web Holdings
Toronto Stock Exchange
FAQ
As of Today at 24:18 UTC, shares in Aurora Cannabis are trading at CA$6.68. This share price information is delayed by 15 minutes.
Shares in Aurora Cannabis last closed at CA$6.68 and the price had moved by -27.07% over the past 365 days. In terms of relative price strength the Aurora Cannabis share price has underperformed the Toronto Stock Exchange 300 Composite Index by -35.16% over the past year.
The overall consensus recommendation for Aurora Cannabis is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAurora Cannabis does not currently pay a dividend.
Aurora Cannabis does not currently pay a dividend.
Aurora Cannabis does not currently pay a dividend.
To buy shares in Aurora Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$6.68, shares in Aurora Cannabis had a market capitalisation of CA$366.45m.
Here are the trading details for Aurora Cannabis:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: ACB
Based on an overall assessment of its quality, value and momentum Aurora Cannabis is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Aurora Cannabis is CA$10.30. That is 54.19% above the last closing price of CA$6.68.
Analysts covering Aurora Cannabis currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.13 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aurora Cannabis. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -19.41%.
As of the last closing price of CA$6.68, shares in Aurora Cannabis were trading -6.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aurora Cannabis PE ratio based on its reported earnings over the past 12 months is 19.88. The shares last closed at CA$6.68.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aurora Cannabis' management team is headed by:
- Ronald Funk - NEC
- Miguel Martin - CEO
- Glen Ibbott - CFO
- Andre Jerome - EVP
- Carey Squires - EVP
- Jillian Swainson - SEC
- Michael Singer - DRC
- Margaret Atkins - IND
- Norma Beauchamp - IND
- Theresa Firestone - IND
- Lance Friedmann - IND
- Chitwant Kohli - IND
- Adam Szweras - IND